Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filippo Pietrantonio

Showing results (231-240 of 323) with videos related to

Pageof 33
Sort By:
European Journal of Cancer (Oxford, England : 1990)|June 20, 2020
Prognostic impact of immune-microenvironment in colorectal liver metastases resected after triplets plus a biologic agent: A pooled analysis of five prospective trialsRoberto Moretto, Salvatore Corallo, Antonino Belfiore, et al.
Clinical Colorectal Cancer|June 10, 2020
Systemic Treatment of Patients With Gastrointestinal Cancers During the COVID-19 Outbreak: COVID-19-adapted Recommendations of the National Cancer Institute of MilanFilippo Pietrantonio, Federica Morano, Monica Niger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2019
Negative Hyperselection of Patients With <i>RAS</i> and <i>BRAF</i> Wild-Type Metastatic Colorectal Cancer Who Received Panitumumab-Based Maintenance TherapyFederica Morano, Salvatore Corallo, Sara Lonardi, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 11, 2023
Exploring circular MET RNA as a potential biomarker in tumors exhibiting high MET activityFrancesca Bersani, Francesca Picca, Deborah Morena, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2021
The Added Value of Baseline Circulating Tumor DNA Profiling in Patients with Molecularly Hyperselected, Left-sided Metastatic Colorectal CancerPaolo Manca, Salvatore Corallo, Adele Busico, et al.
British Journal of Cancer|June 28, 2017
Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancerDaniele Oddo, Giulia Siravegna, Annunziata Gloghini, et al.
British Journal of Cancer|September 25, 2023
Mismatch Repair system protein deficiency as a resistance factor for locally advanced rectal adenocarcinoma patients receiving neoadjuvant chemo-radiotherapyAndrea Pretta, Pina Ziranu, Riccardo Giampieri, et al.
Clinical Colorectal Cancer|March 14, 2026
The Impact of Surgical Resection in Early Onset Colorectal Cancer Patients With Liver Limited DiseaseAndrea Pretta, Pina Ziranu, Francesca Bergamo, et al.
British Journal of Cancer|November 28, 2024
Early onset metastatic colorectal cancer patients as a distinctive clinical and molecular phenomenonAndrea Pretta, Pina Ziranu, Eleonora Perissinotto, et al.
Clinical Colorectal Cancer|December 19, 2018
Perioperative Bevacizumab-based Triplet Chemotherapy in Patients With Potentially Resectable Colorectal Cancer Liver MetastasesFilippo Pietrantonio, Christian Cotsoglou, Giovanni Fucà, et al.
Pageof 33

Showing results (231-240 of 323) with videos related to

Sort By:
Pageof 33
European Journal of Cancer (Oxford, England : 1990)|June 20, 2020
Prognostic impact of immune-microenvironment in colorectal liver metastases resected after triplets plus a biologic agent: A pooled analysis of five prospective trialsRoberto Moretto, Salvatore Corallo, Antonino Belfiore, et al.
Clinical Colorectal Cancer|June 10, 2020
Systemic Treatment of Patients With Gastrointestinal Cancers During the COVID-19 Outbreak: COVID-19-adapted Recommendations of the National Cancer Institute of MilanFilippo Pietrantonio, Federica Morano, Monica Niger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2019
Negative Hyperselection of Patients With <i>RAS</i> and <i>BRAF</i> Wild-Type Metastatic Colorectal Cancer Who Received Panitumumab-Based Maintenance TherapyFederica Morano, Salvatore Corallo, Sara Lonardi, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 11, 2023
Exploring circular MET RNA as a potential biomarker in tumors exhibiting high MET activityFrancesca Bersani, Francesca Picca, Deborah Morena, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2021
The Added Value of Baseline Circulating Tumor DNA Profiling in Patients with Molecularly Hyperselected, Left-sided Metastatic Colorectal CancerPaolo Manca, Salvatore Corallo, Adele Busico, et al.
British Journal of Cancer|June 28, 2017
Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancerDaniele Oddo, Giulia Siravegna, Annunziata Gloghini, et al.
British Journal of Cancer|September 25, 2023
Mismatch Repair system protein deficiency as a resistance factor for locally advanced rectal adenocarcinoma patients receiving neoadjuvant chemo-radiotherapyAndrea Pretta, Pina Ziranu, Riccardo Giampieri, et al.
Clinical Colorectal Cancer|March 14, 2026
The Impact of Surgical Resection in Early Onset Colorectal Cancer Patients With Liver Limited DiseaseAndrea Pretta, Pina Ziranu, Francesca Bergamo, et al.
British Journal of Cancer|November 28, 2024
Early onset metastatic colorectal cancer patients as a distinctive clinical and molecular phenomenonAndrea Pretta, Pina Ziranu, Eleonora Perissinotto, et al.
Clinical Colorectal Cancer|December 19, 2018
Perioperative Bevacizumab-based Triplet Chemotherapy in Patients With Potentially Resectable Colorectal Cancer Liver MetastasesFilippo Pietrantonio, Christian Cotsoglou, Giovanni Fucà, et al.
Pageof 33